SWK (OTCMKTS:SWKH) issued an update on its fourth quarter 2019
Pre-Market earnings guidance on Thursday morning. The company provided EPS guidance of 0.33-0.36 for the period. The company issued revenue guidance of $9.1-9.6 million.SWK also updated its FY 2019
Pre-Market guidance to 1.63-1.66 EPS.
SWK stock traded up $1.25 on Thursday, reaching $13.00. 6,775 shares of the stock were exchanged, compared to its average volume of 10,325. The stock has a market cap of $94.36 million, a PE ratio of 8.55 and a beta of 0.02. SWK has a twelve month low of $6.12 and a twelve month high of $14.20. The firm has a fifty day moving average price of $13.02 and a two-hundred day moving average price of $12.72.
SWK Company Profile
SWK Holdings Corporation, a specialized finance company, focuses on the healthcare sector. It intends to provide customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.
Featured Article: What is a CD ladder?
Receive News & Ratings for SWK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWK and related companies with MarketBeat.com's FREE daily email newsletter.